Pacira BioSciences (PCRX) Long-Term Investments (2014 - 2023)

Pacira BioSciences' Long-Term Investments history runs 10 years deep, the most recent figure standing at $2.4 million for Q4 2023.

• In Q4 2023, Long-Term Investments fell 93.52% year-over-year to $2.4 million; the TTM figure through Dec 2023 stood at $2.4 million (down 93.52% YoY), while the FY2023 annual figure was $2.4 million, down 93.52% from the prior year.
• Long-Term Investments was $2.4 million for Q4 2023 at Pacira BioSciences, down from $8.3 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $70.6 million in Q3 2019 to a low of $2.4 million in Q4 2023.
• Historically, Long-Term Investments has averaged $23.1 million across 5 years, with a median of $15.7 million in 2020.
• The sharpest annual moves came in 2019 and 2023: Long-Term Investments jumped 1484.13% in 2019, then slumped 93.52% in 2023.
• A 5-year view of Long-Term Investments shows it stood at $11.0 million in 2019, then climbed by 27.78% to $14.0 million in 2020, then jumped by 149.45% to $35.0 million in 2021, then increased by 6.4% to $37.2 million in 2022, then plunged by 93.52% to $2.4 million in 2023.
• The last three Long-Term Investments figures came in at $2.4 million (Q4 2023), $8.3 million (Q1 2023), and $37.2 million (Q4 2022), per Business Quant data.